Related Experiment Video
Updated: Jun 11, 2025
06:07
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
2.3K
Exploring HIV-1 Maturation: A New Frontier in Antiviral Development.
Aidan McGraw1, Grace Hillmer1, Stefania M Medehincu1
1Department Biology, College of Arts and Sciences, American University, Washington, DC 20016, USA.
Viruses
|September 28, 2024
Summary
HIV-1 maturation transforms immature virions into infectious particles through Gag polyprotein cleavage. Host factors and environmental conditions significantly influence this critical viral replication step.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- HIV-1 virion maturation is crucial for producing infectious viral particles.
- Maturation involves the cleavage of Gag and Gag-Pol polyproteins by the viral protease.
- This process transforms immature, noninfectious virions into infectious ones.
Purpose of the Study:
- To review the processes of HIV-1 virion maturation and Env glycoprotein recruitment.
- To emphasize the role of host cell factors and environmental conditions in maturation.
- To discuss technologies for assessing maturation and antivirals targeting this step.
Main Methods:
- Literature review of HIV-1 replication and maturation processes.
- Analysis of host factors influencing virion maturation (e.g., cyclophilin A, IP6, lipid rafts).
- Discussion of microscopic technologies and antiviral strategies targeting HIV-1 maturation.
Main Results:
- Virion maturation is essential for viral infectivity, influencing Env glycoprotein distribution and CD4 receptor interaction.
- Host factors like cyclophilin A, IP6, and sphingomyelin-containing lipid rafts play significant roles.
- Microscopic techniques aid in assessing maturation, and antivirals targeting this step offer therapeutic potential.
Conclusions:
- HIV-1 maturation is a complex process regulated by viral proteins and host factors.
- Understanding maturation mechanisms is key to developing effective long-acting antiretroviral therapies.
- Targeting virion maturation presents a promising strategy for combating HIV-1 infection.
Keywords:
Förster resonance energy transfer (FRET)GagGag-Polallosteric integrase inhibitor (ALLINI)capsidcapsid inhibitor (CAI)human immunodeficiency virus type I (HIV-1)maturationmaturation inhibitor (MI)protease inhibitor (PI)More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
45.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K
02:33Retroviruses
12.2K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.2K